Skip to content

VItamin C in Thermal injuRY: The VICToRY Trial A phase III multi-center randomized trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504772-21-00
Acronym
19-211
Enrollment
339
Registered
2023-07-24
Start date
2022-11-22
Completion date
Unknown
Last updated
2025-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severely burned patients

Brief summary

• Persistent organ dysfunction (PODS)+death at 28 days, a novel composite endpoint that combines being alive and being free of organ support (inotropes or vasopressors, renal replacement therapy and mechanical ventilation).

Detailed description

• The most important secondary endpoint of this trial will be “time to discharge alive from hospital“., • The other secondary outcomes will be the components of 28-day POD which include mortality, use of inotropes or vasopressors or mechanical circulatory assistance, renal replacement therapy and mechanical ventilation and POD-free days in the first 28 days.

Interventions

DRUGD5W (dextrose 5% in water)
DRUGASCORBIC ACID

Sponsors

Queen's University
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
• Persistent organ dysfunction (PODS)+death at 28 days, a novel composite endpoint that combines being alive and being free of organ support (inotropes or vasopressors, renal replacement therapy and mechanical ventilation).

Secondary

MeasureTime frame
• The most important secondary endpoint of this trial will be “time to discharge alive from hospital“., • The other secondary outcomes will be the components of 28-day POD which include mortality, use of inotropes or vasopressors or mechanical circulatory assistance, renal replacement therapy and mechanical ventilation and POD-free days in the first 28 days.

Countries

Belgium, France, Germany, Italy, Portugal

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026